Beth-Ann Coller,Vidya Pai,Carolyn L. Weeks-Levy,Steven A. Ogata
申请号：
US15331596
公开号：
US10039820B2
申请日:
2016.10.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A West Nile virus vaccine for human use is described that preferably contains a recombinantly produced form of truncated West Nile virus envelope glycoprotein and aluminum adjuvant. The vaccine is acceptable for use in the general population, including immunosuppressed, immunocompromised, and immunosenescent individuals. The vaccine is safe and effective for use in all healthy and at-risk populations. A pharmaceutically acceptable vehicle may also be included in the vaccine.
